For the pediatric indication, we plan to initiate the VAX-31 infant Phase 2 study by the end of January 2025. For the adult ...
Watch “This is Now,” live from the Hawaii News Now Digital Center, weekdays on KHNL at 12 p.m. and on all of our streaming ...
14h
Investigational New Drug Application Cleared by FDA; Company Expects to Initiate VAX-31 Infant Phase 2 Study by the End of January 2025 -- -- VAX-31 Adult Indication: ...
Imagine you are a parent of a 6-month-old and are looking to introduce solid foods to your baby. You are not sure what and ...
The following is a summary of "Nirsevimab and Acute Bronchiolitis Episodes in Pediatric Emergency Departments," published in the September 2024 issue of Pediatrics by Martínez et al. In the 2023–2024 ...
Company Reported Positive Topline Safety, Tolerability and Immunogenicity Data from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal ...
pediatric medical subspecialists and pediatric surgical specialists whose mission is to attain optimal physical, mental, and social health and well-being for all infants, children, adolescents, and ...
Research indicates 15% to 40% of infants with the disease die. The earlier a premature baby is born, the higher their risk of ...
St. Francisville Rehab Services recently broke ground on a new dedicated pediatric facility at 10281 Gould Drive adjacent to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback